Aim: Evaluating QOL of juvenile onset open angle glaucoma (JOAG) patients using utility based assessment. Methods: QOL using time trade off utility values were analysed in 70 JOAG patients, and were compared with 108 adult onset POAG patients. Relationship of utility values to parameters like age at diagnosis, visual acuity, mean deviation, number of medications and surgery, duration of the disease, level of education and socio economic status was assessed. Results: Overall there was a decrease of utility values with increasing age (r= -0.3, p<0.001). Mean utility score among JOAG patients was (0.80} 0.18) significantly greater than among adult POAG patients (0.64} 0.28), p=0.000. Among JOAG patients, those needing topical anti -glaucoma medications and those with visual acuity worse than 6/12 in the better eye had lower utility value (p=0.008 and p=0.002 respectively). Conclusion: Utility values among juvenile glaucoma patients were better compared to adult POAG patients.
O nce diagnosed with glaucoma, patients remain under an anxiety of tedious investigations, need of life long therapy, the cost constraints, side effects of medications, surgery and the need for regular follow ups. Priorities of patients are important in assessing the difficulties they face. Severity of glaucoma further influences the relative importance of their priorities.
Quality of life (QOL) may be defined as subjective well-being which depends on patient's values, priorities, experiences, and aspirations and reflects the difference between the hopes and expectations of a person and their experiences. Assessment of QOL has been used to understand the impact of various factors linked to the disease process on patient's life. It is also of benefit in micro and macro level health care decision making.
In this study we aimed to determine the impact of glaucoma on the quality of life of patients in the juvenile age group and compare it with adult onset primary open angle glaucoma patients, using utility based analysis.
MatEriaLs and MEthods
The study was carried out using a standard questionnaire for patients with juvenile and adult onset primary open angle glaucoma managed in a tertiary care centre. Inclusion criterion for JOAG was, cases of established primary open angle glaucoma between 15-40 years of age while for POAG was, those diagnosed with primary open angle glaucoma after the age of 40 years. Patients with any other coexistent ocular condition that could impair vision like retinal or neural pathology, secondary glaucomas and angle closure glaucoma were excluded .
In the time-trade off utility analysis, patients were asked the number of years of their presumed remaining years of life that they were willing to trade off for perfect vision and a life without glaucoma. The time-trade off utility values were calculated by dividing the number of years traded by the number of expected remaining years of life and subtracting this proportion from 1.0. A utility value of 1.0 indicates a state of perfect health, whereas a utility value of 0 indicates death .
Following parameters were recorded: LogMAR visual acuity in the better and the worse eye, mean deviation in the better and worse eye, number of surgeries the patient had undergone, number of topical anti glaucoma medications the patient was on, duration of the disease, educational level (which was categorised as; no formal education, primary school, high school, graduate and post graduate) and monthly family income ( converted to US dollars).
Statistical analysis: A sample size of 48 in each group was needed to detect a 25% difference in the mean utility values between the 2 groups, with a standard deviation of 0.15, if the power was 0.8 and type 1 alpha error was 0.05. The means, standard deviations (SD) and 95% confidence intervals were calculated for utility values. Pearson's coefficient analysis was used to find the correlation between these variables and utility values. Differences of means between groups were analysed using Students independent 't' test or the one way ANOVA. To look for factors that determined utility values (dependent variable) in either group a multiple linear regression using the enter method for all variables was carried out. A p value <0.05 was considered significant.
rEsuLts
The mean age at diagnosis of JOAG patients was 26±9.8 years and the mean age of POAG patients was 62±11.2 years.
Overall there was a decrease of utility values with increasing age among glaucoma patients (r=-0.3, p<0.001). The mean utility scores among JOAG patients were significantly better than adult POAG patients; 0.80±0.18 vs 0.64± 0.28 respectively (p=0.00) .
Among JOAG patients, the utility scores were not significantly different between males and females. JOAG patients in our study expected to live another 44.5±11.6 70th AIOC Proceedings, Cochin 2012 years on an average. Of these, they were willing to give up 8± 7.7 years on an average, for perfect vision. Twelve patients (20%) were not willing to trade off any years of their lives while the remaining (80%) were willing to trade off some years of their lives for perfect vision. Mean age of those willing to trade off some years of their remaining life; 36.2 ±9.4 years, was not significantly different from those not willing to trade off ; 30.1±2.5years. (p=0.12).
On an average the adult POAG patients expected to live 19± 10 .4 years and were willing to trade off 6.6± 5.6 years for perfect vision. Sixteen adult POAG patients (15%) were not willing to trade off any years of their life.
Among JOAG patients, factors like age at diagnosis (r = 0.19, p = 0 .34), duration of disease(r = 0.01, p=0.9) family income or severity of visual field defect did not correlate with the utility score. Those patients not using topical medication had a better utility score (0.89± 0.09) compared to those using one or more topical anti glaucoma drugs (0.77± 0.19); (p=0.002) to control their IOP.
None of the JOAG patients had associated systemic disease. Among adult POAG patients, 42 (39%) had some coexisting systemic disorder. Utility values of adult POAG patients with coexisting systemic disease (0.62± 0.3) was not significantly different from those without any systemic disease (0.66± 0.28) (p=0.58).
discussion
The mean utility values among our juvenile glaucoma patients were greater than among adults of a similar ethnic and cultural background. Jampel et al, reported utility values of 0.91 among adult glaucoma patients in U.S.A. Most of their patients had early glaucoma or were glaucoma suspects. Saw et al reported a utility value of 0.88 in their Chinese patients from Singapore. Their study patients had an average age of 65 years, and only 16% had a pattern standard deviation worse than 10dB. In contrast more than three fourths of our JOAG patients at an average age of 25 years had advanced visual field defects.
Among our cohort of patients there was a trend of worsening QOL with increasing age. This decreasing QOL with increasing age was also observed by Sun et al in their Chinese patients with angle closure glaucoma.
15
Increasing age is known to decrease the quality of life. Younger adults have different perceptions of life and different priorities that determine their QOL compared to older adults. Reasons for younger patients perceiving a better QOL compared to older glaucoma patients could be related to their greater adaptability to changing needs especially with the social support systems available, better cognitive abilities and probably their greater will power. Also, younger patients may not fully understand the long term disability associated with the disease as long as their visual acuity is good in at least one eye. The absence of systemic illnesses and other concomitant ocular problems among younger compared to older glaucoma patients could also be contributory though we did not find absence of systemic disease to be associated with better utility values among older glaucoma patients in our study. 
70th AIOC Proceedings, Cochin 2012
In our study eighty percent of JOAG patients were willing to trade off at least some years of their lives for perfect vision and a glaucoma free life. This in contrast to the studies among Chinese and American glaucoma patients where only a third were willing to trade off some years of their lives for perfect vision. This could be because more than three fourths of our patients presented with advanced glaucoma while less than a third of the patients in the latter studies presented with advanced disease. However despite advanced field defects and the fact that one fifth of our patients had lost vision in one eye due to glaucoma, JOAG patients were not willing to give up many years of their remaining life for perfect vision. Patients who lose vision in one eye remain under fear of losing sight altogether. Surprisingly however, even patients who had lost vision due to glaucoma in one eye, did not have significantly worse utility values. This could be because these patients maintained reasonably good vision in their better eye. It is known that visual acuity in the better eye correlates more closely with utility values which was also found to be so among our patients with monocular blindness due to glaucoma. The impact of these findings is that, if the QOL is not significantly affected then there is a greater likelihood that it may impair compliance and be the reason for non adherence to glaucoma therapy. This is confirmed by the study of Reese et al 23 who found non adherence to be more common in younger patients.
The quality of life of younger glaucoma patients is better than adult POAG patients and it is not affected by their visual field deficit as long as their visual acuity in the better eye is maintained. If glaucoma does not impair the quality of life there is a greater likelihood that it may be associated with poorer compliance and greater non adherence to glaucoma therapy among the younger patients.
